Spyre Therapeutics, Inc. (SYRE)

33.52 +0.46 (+1.39%) USD  |  NASDAQ  |  Dec 18, 15:37
More

Spyre Therapeutics Operating Income (TTM)

Operating Income (TTM) Chart

View Operating Income (TTM) for SYRE.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Operating Income (TTM) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Operating Income (TTM) Range, Past 5 Years

View Operating Income (TTM) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Operating Income (TTM) Benchmarks

View Operating Income (TTM) Benchmarks
Start Trial
PTC Therapeutics, Inc. Upgrade
NovaBay Pharmaceuticals, Inc. Upgrade
Palatin Technologies, Inc. Upgrade
Theriva Biologics, Inc. Upgrade
Oragenics, Inc. Upgrade